Evidence map›Paper›PMID 36422564›Full record

ArticlePharmaceuticals (Basel, Switzerland)2022

Integrated Chemical Characterization, Network Pharmacology and Transcriptomics to Explore the Mechanism of Sesquiterpenoids Isolated from

Xinyuan Ye, Long Wang, Xin Yang, Jie Yang, Jie Zhou, Cai Lan, Fahsai Kantawong, Warunee Kumsaiyai, Jianming Wu, Jing Zeng

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Xinyuan YeSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Long WangSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Xin YangSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Jie YangSchool of Basic Medical Science, Southwest Medical University, Luzhou 646000, China.
Jie ZhouSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Cai LanSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.
Fahsai KantawongFaculty Associated Medical Sciences, Department of Medical Technology, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0003-0323-3021
Warunee KumsaiyaiFaculty Associated Medical Sciences, Department of Medical Technology, Chiang Mai University, Chiang Mai 50200, Thailand.
Jianming WuSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.ORCID 0000-0002-6136-7469
Jing ZengSchool of Pharmacy, Southwest Medical University, Luzhou 646000, China.ORCID 0000-0003-0857-2217
Southwest Medical University · CNChiang Mai University · TH

Funding

National Natural Science Foundation of China 82273889, 8220141822, and 82074129Science and Technology Department of Sichuan Province 2019YFSY0042 and 2022JDJQ0061Southwest Medical University 2020LZXNYDZ03, 2020LZXNYDP01 and 2021ZKMS044
6 · The paper itself

Abstract

Chronic myelogenous leukemia (CML) is a serious threat to human health, while drugs for CML are limited. Herbal medicines with structural diversity, low toxicity and low drug resistance are always the most important source for drug discoveries.

Indexed as

chronic myelogenous leukemiaGynura divaricata (L.) DC.molecular networkingnetwork pharmacologyRNA sequencingsesquiterpenoids

Identifiers

PMID36422564
PMCPMC9693606
OpenAlexW4309742855

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.